13th May’21 – Coverage closure on Revathi, Update on SIS and Mar’21 earnings update on Canfin
This content is for premium members only.
Subscribe
Subscribe
Already a member? Log in here
6th Nov’20 – Sep’20 earnings update on Suven Pharma and Can Fin Homes
Dear Members, We have released 6th Nov’20 – Sep’20 earnings update on Suven Pharmaceuticals and Can Fin Homes. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 6th Nov’20 Suven Pharmaceuticals (NSE – SUVENPHAR) – May’17 Alpha stock CMP – 325.75 (BSE); 326.60 (NSE) Rating – Positive – 5% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Suven Pharmaceuticals got demerged from Suven Lifesciences with the entire revenue generating businesses consisting of CRAMS,…
28th Aug’20 – Coverage closure on ABB Power and Jun’20 earnings update on Can Fin Homes
This content is for premium members only.
Subscribe
Subscribe
Already a member? Log in here
7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs
Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20 Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…